Dr Emelia J. Benjamin: Atrial Fibrillation Is Common and Increasing in Incidence
July 23rd 2023Emelia J. Benjamin, MD, ScM, Boston University Chobanian and Avedisian School of Medicine, is the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award. Here she describes what atrial fibrillation is, how the condition announces itself, and why this area of cardiovascular medicine is receiving so much attention.
Watch
Dr G. B. John Mancini Underscores the Importance of Preventive Cardiology
July 22nd 2023The ASPC Congress on CVD Prevention is taking place in Arlington, Texas, July 21-23. Here, G.B. John Mancini, MD, University of British Columbia, emphasizes the importance of having an international perspective on preventive cardiology.
Watch
Dr Franco Locatelli Discusses the Treatment of Patients with cGvHD
July 21st 2023Franco Locatelli, MD, PhD, head of the Department of Pediatric Hematology and Oncology at IRCCS Bambino Gesu Children’s Hospital in Rome, discusses the treatment of both adult and pediatric patients with chronic graft versus host disease (cGvHD).
Watch
Dr Judite Blanc Discusses Digging Deeper, Getting to the Root of Sleep Health
July 21st 2023Judite Blanc, PhD, is lead author on the abstract, “Social Determinants of Sleep Disorders Among Multiethnic Americans in the NIH All of Us Research Program,” which was presented on June 5th at the SLEEP 2023 conference.
Watch
Dr Wojciech Jurczak Discusses Changing Treatment Options for R/R DLBCL
July 20th 2023Wojciech Jurczak, MD, PhD, head of the Department of Oncology at Maria Sklodowska-Curie National Research Institute of Oncology, discusses the changing therapy landscape for relapsed or refractory diffuse large B-cell lymphoma (DLBCL).
Watch
Dr Melinda Gooderham: Emerging vs Traditional Therapies for Patients With Atopic Dermatitis
July 6th 2023Melinda Gooderham, MD, MSc, FRCPC, Peterborough Regional Health Centre in Ontario, Canada, breaks down which subgroup of patients with atopic dermatitis (AD) may benefit the most from emerging therapies, as well as the advantages and disadvantages of these therapies.
Watch
Poster Talks Explore How Policy, Payer Incentives Affect Cancer Care, Outcomes
July 3rd 2023Speakers elaborated on health care delivery and regulatory policy posters presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting. This article will appear in the ASCO recap edition of Evidence-Based Oncology.
Read More
Earlier Use of CAR T Cells Holds Promise in Blood Cancers, but Access Remains an Issue
June 23rd 2023A panel of experts at the American Society of Clinical Oncology Annual Meeting presented the latest research and equity considerations for chimeric antigen receptor (CAR) T-cell therapy in hematological cancers.
Read More
ASCO, ESMO Panel Highlights Progress and Disparities in Lung and Colorectal Cancer Screening
June 22nd 2023A session chaired by ASCO and ESMO leadership included experts on the latest lung and colorectal cancer screening technologies and persistent disparities in screening access and uptake.
Read More
New Epcoritamab Data Show Strong Results in B-Cell Lymphomas
June 22nd 2023Data presented at the 2023 European Hematology Association Annual Meeting showed positive outcomes in patients with follicular lymphoma and large B-cell lymphoma, and further evaluation in diffuse large B-cell lymphoma is ongoing.
Read More
Dr Andy Blauvelt: Drug Approval, Accessibility Challenges in Treating Patients With AD
June 22nd 2023Andy Blauvelt, MD, MBA, president of Oregon Medical Research Center, discusses challenges many physicians face in getting approved for the most effective drugs to treat patients with atopic dermatitis (AD).
Watch
Inequalities Within and Between Practices Contribute to NGS Testing Disparities in NSCLC
June 15th 2023A study presented at the American Society of Clinical Oncology Annual Meeting found practice- and provider-level racial and ethnic inequities in rates of next-generation sequencing (NGS) testing for patients with advanced non–small cell lung cancer (NSCLC) treated in the community setting.
Read More
Dr Susan Escudier on How Oncologists and PCPs Can Work Together to Improve Value-Based Care
June 14th 2023Susan Escudier, MD, FACP, vice president of value-based and quality programs for Texas Oncology, discusses how collaboration between oncologists and primary care physicians (PCPs) can improve patient satisfaction and outcomes.
Watch
Dr Courtney DiNardo Sheds Light on FDA Fast Track Designation and Its Impact on Drug Development
June 11th 2023Courtney DiNardo, MD, MSCE, the lead author on a study presented at EHA 2023 evaluating a new therapy for chronic myelomonocytic leukemia and acute myeloid leukemia, discusses the FDA Fast Track Designation for IO-202 and strategies for raising awareness and improving diversity in clinical trials.
Watch
Researchers Deliver Updates on Efforts Toward Eradicating CLL
June 11th 2023Panelists provided a wide-ranging view of the current avenues being investigated to optimize the treatment of chronic lymphocytic leukemia (CLL), including minimal residual disease assessment, combination regimens, and chimeric antigen receptor T-cell therapy.
Read More
Dr Yael Cohen Explains the Barriers to Accessing Triplet Combination Therapies for MM
June 11th 2023More data is emerging on the efficacy of several triplet therapies to treat single-class refractory multiple myeloma (MM), potentially giving patients more therapy options than ever before, according to Tel-Aviv Sourasky Medical Center's Yael Cohen, MD, at the European Hematology Association 2023 Congress.
Watch
Dr Wojciech Jurczak Gives Insight Into the Phase 2 L-MIND Trial in DLBCL
June 11th 2023Wojciech Jurczak, MD, PhD, lead researcher on the L-MIND study evaluating a new treatment combination in diffuse large B-cell lymphoma (DLBCL), gave an overview of the trial results that were presented at the European Hematology Association 2023 Congress.
Watch
EHA 2023 Late-Breaking Abstracts Offer Sneak Peek at the Future of Hematology
June 11th 2023The late-breaking oral session at the European Hematology Association (EHA) 2023 Congress featured newly emerged data from abstracts submitted after the deadline, including outcomes from trials in polycythemia vera, acute myeloid leukemia, and more.
Read More